Asset Management
Compare Stocks
4 / 10Stock Comparison
SCM vs CSWC vs ARCC vs GAIN
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
Asset Management
Asset Management
SCM vs CSWC vs ARCC vs GAIN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Asset Management | Asset Management | Asset Management | Asset Management |
| Market Cap | $274M | $1.43B | $13.61B | $657M |
| Revenue (TTM) | $104M | $164M | $3.15B | $90M |
| Net Income (TTM) | $27M | $103M | $1.15B | $130M |
| Gross Margin | 76.1% | 66.5% | 75.7% | 68.6% |
| Operating Margin | 61.6% | 48.5% | 69.7% | 72.7% |
| Forward P/E | 9.4x | 10.1x | 9.9x | 40.7x |
| Total Debt | $593M | $956M | $15.99B | $456M |
| Cash & Equiv. | $20M | $43M | $924M | $14M |
SCM vs CSWC vs ARCC vs GAIN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Stellus Capital Inv… (SCM) | 100 | 120.1 | +20.1% |
| Capital Southwest C… (CSWC) | 100 | 171.6 | +71.6% |
| Ares Capital Corpor… (ARCC) | 100 | 128.5 | +28.5% |
| Gladstone Investmen… (GAIN) | 100 | 148.9 | +48.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SCM vs CSWC vs ARCC vs GAIN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SCM is the clearest fit if your priority is value.
- Lower P/E (9.4x vs 9.9x)
CSWC is the #2 pick in this set and the best alternative if income & stability and bank quality is your priority.
- Dividend streak 3 yrs, beta 0.84, yield 10.2%
- NIM 7.0% vs SCM's 0.0%
- 10.2% yield, 3-year raise streak, vs GAIN's 10.0%, (1 stock pays no dividend)
- +34.0% vs SCM's -13.7%
ARCC carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 32.9%, EPS growth -23.8%
- 32.9% NII/revenue growth vs GAIN's -12.9%
- Efficiency ratio 0.1% vs CSWC's 0.2% (lower = leaner)
- Efficiency ratio 0.1% vs CSWC's 0.2%
GAIN is the clearest fit if your priority is long-term compounding and sleep-well-at-night.
- 319.3% 10Y total return vs CSWC's 234.2%
- Lower volatility, beta 0.53, Low D/E 91.3%, current ratio 3.69x
- Beta 0.53, yield 10.0%, current ratio 3.69x
- Beta 0.53 vs CSWC's 0.84, lower leverage
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 32.9% NII/revenue growth vs GAIN's -12.9% | |
| Value | Lower P/E (9.4x vs 9.9x) | |
| Quality / Margins | Efficiency ratio 0.1% vs CSWC's 0.2% (lower = leaner) | |
| Stability / Safety | Beta 0.53 vs CSWC's 0.84, lower leverage | |
| Dividends | 10.2% yield, 3-year raise streak, vs GAIN's 10.0%, (1 stock pays no dividend) | |
| Momentum (1Y) | +34.0% vs SCM's -13.7% | |
| Efficiency (ROA) | Efficiency ratio 0.1% vs CSWC's 0.2% |
SCM vs CSWC vs ARCC vs GAIN — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
GAIN leads in 2 of 6 categories
SCM leads 1 • CSWC leads 1 • ARCC leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
GAIN leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
ARCC is the larger business by revenue, generating $3.1B annually — 35.0x GAIN's $90M. GAIN is the more profitable business, keeping 72.7% of every revenue dollar as net income compared to SCM's 26.1%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $104M | $164M | $3.1B | $90M |
| EBITDAEarnings before interest/tax | $0 | $142M | $2.0B | $58M |
| Net IncomeAfter-tax profit | $27M | $103M | $1.1B | $130M |
| Free Cash FlowCash after capex | $83.64T | -$69M | $1.1B | -$82M |
| Gross MarginGross profit ÷ Revenue | +76.1% | +66.5% | +75.7% | +68.6% |
| Operating MarginEBIT ÷ Revenue | +61.6% | +48.5% | +69.7% | +72.7% |
| Net MarginNet income ÷ Revenue | +26.1% | +43.1% | +41.3% | +72.7% |
| FCF MarginFCF ÷ Revenue | -235.8% | -132.6% | +36.3% | +126.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -40.0% | +113.3% | -63.9% | +58.1% |
Valuation Metrics
SCM leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 9.3x trailing earnings, GAIN trades at a 43% valuation discount to CSWC's 16.3x P/E. On an enterprise value basis, ARCC's 13.1x EV/EBITDA is more attractive than CSWC's 27.4x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $274M | $1.4B | $13.6B | $657M |
| Enterprise ValueMkt cap + debt − cash | $847M | $2.3B | $28.7B | $1.1B |
| Trailing P/EPrice ÷ TTM EPS | 10.18x | 16.32x | 10.19x | 9.28x |
| Forward P/EPrice ÷ next-FY EPS est. | 9.37x | 10.06x | 9.92x | 40.66x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.99x | — |
| EV / EBITDAEnterprise value multiple | 13.33x | 27.43x | 13.09x | 16.82x |
| Price / SalesMarket cap ÷ Revenue | 2.65x | 8.71x | 4.33x | 7.31x |
| Price / BookPrice ÷ Book value/share | 0.00x | 1.39x | 0.93x | 1.22x |
| Price / FCFMarket cap ÷ FCF | — | — | 11.92x | 5.77x |
Profitability & Efficiency
GAIN leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
GAIN delivers a 21.9% return on equity — every $100 of shareholder capital generates $22 in annual profit, vs $0 for SCM. SCM carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to ARCC's 1.12x. On the Piotroski fundamental quality scale (0–9), ARCC scores 4/9 vs CSWC's 1/9, reflecting mixed financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +0.0% | +10.3% | +8.1% | +21.9% |
| ROA (TTM)Return on assets | +0.0% | +4.8% | +3.8% | +10.5% |
| ROICReturn on invested capital | +0.0% | +3.5% | +5.7% | +5.3% |
| ROCEReturn on capital employed | +0.0% | +4.6% | +7.5% | +6.8% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 1 | 4 | 4 |
| Debt / EquityFinancial leverage | 0.00x | 1.08x | 1.12x | 0.91x |
| Net DebtTotal debt minus cash | $573M | $913M | $15.1B | $441M |
| Cash & Equiv.Liquid assets | $20M | $43M | $924M | $14M |
| Total DebtShort + long-term debt | $593M | $956M | $16.0B | $456M |
| Interest CoverageEBIT ÷ Interest expense | 1.82x | 2.91x | 2.98x | 1.58x |
Total Returns (Dividends Reinvested)
Evenly matched — CSWC and GAIN each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GAIN five years ago would be worth $17,205 today (with dividends reinvested), compared to $12,848 for SCM. Over the past 12 months, CSWC leads with a +34.0% total return vs SCM's -13.7%. The 3-year compound annual growth rate (CAGR) favors CSWC at 20.7% vs SCM's -1.0% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -21.0% | +11.4% | -4.9% | +20.7% |
| 1-Year ReturnPast 12 months | -13.7% | +34.0% | +0.4% | +30.8% |
| 3-Year ReturnCumulative with dividends | -3.0% | +75.8% | +34.2% | +56.5% |
| 5-Year ReturnCumulative with dividends | +28.5% | +51.4% | +47.0% | +72.0% |
| 10-Year ReturnCumulative with dividends | +135.4% | +234.2% | +139.2% | +319.3% |
| CAGR (3Y)Annualised 3-year return | -1.0% | +20.7% | +10.3% | +16.1% |
Risk & Volatility
Evenly matched — CSWC and GAIN each lead in 1 of 2 comparable metrics.
Risk & Volatility
GAIN is the less volatile stock with a 0.53 beta — it tends to amplify market swings less than CSWC's 0.84 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CSWC currently trades 98.2% from its 52-week high vs SCM's 62.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.70x | 0.84x | 0.77x | 0.53x |
| 52-Week HighHighest price in past year | $15.39 | $24.43 | $23.42 | $17.14 |
| 52-Week LowLowest price in past year | $8.43 | $19.37 | $17.40 | $13.11 |
| % of 52W HighCurrent price vs 52-week peak | +62.8% | +98.2% | +81.0% | +96.3% |
| RSI (14)Momentum oscillator 0–100 | 50.9 | 63.7 | 56.7 | 69.9 |
| Avg Volume (50D)Average daily shares traded | 207K | 664K | 7.5M | 371K |
Analyst Outlook
CSWC leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: SCM as "Hold", CSWC as "Buy", ARCC as "Buy", GAIN as "Hold". Consensus price targets imply 37.0% upside for SCM (target: $13) vs -9.1% for GAIN (target: $15). For income investors, CSWC offers the higher dividend yield at 10.20% vs ARCC's 2.02%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $13.25 | $22.50 | $21.88 | $15.00 |
| # AnalystsCovering analysts | 8 | 10 | 32 | 7 |
| Dividend YieldAnnual dividend ÷ price | — | +10.2% | +2.0% | +10.0% |
| Dividend StreakConsecutive years of raises | 0 | 3 | 0 | 0 |
| Dividend / ShareAnnual DPS | — | $2.45 | $0.38 | $1.66 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.1% | 0.0% | 0.0% | 0.0% |
GAIN leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SCM leads in 1 (Valuation Metrics). 2 tied.
SCM vs CSWC vs ARCC vs GAIN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SCM or CSWC or ARCC or GAIN a better buy right now?
For growth investors, Ares Capital Corporation (ARCC) is the stronger pick with 32.
9% revenue growth year-over-year, versus -12. 9% for Gladstone Investment Corporation (GAIN). Gladstone Investment Corporation (GAIN) offers the better valuation at 9. 3x trailing P/E (40. 7x forward), making it the more compelling value choice. Analysts rate Capital Southwest Corporation (CSWC) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SCM or CSWC or ARCC or GAIN?
On trailing P/E, Gladstone Investment Corporation (GAIN) is the cheapest at 9.
3x versus Capital Southwest Corporation at 16. 3x. On forward P/E, Stellus Capital Investment Corporation is actually cheaper at 9. 4x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — SCM or CSWC or ARCC or GAIN?
Over the past 5 years, Gladstone Investment Corporation (GAIN) delivered a total return of +72.
0%, compared to +28. 5% for Stellus Capital Investment Corporation (SCM). Over 10 years, the gap is even starker: GAIN returned +319. 3% versus SCM's +135. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SCM or CSWC or ARCC or GAIN?
By beta (market sensitivity over 5 years), Gladstone Investment Corporation (GAIN) is the lower-risk stock at 0.
53β versus Capital Southwest Corporation's 0. 84β — meaning CSWC is approximately 56% more volatile than GAIN relative to the S&P 500. On balance sheet safety, Stellus Capital Investment Corporation (SCM) carries a lower debt/equity ratio of 0% versus 112% for Ares Capital Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — SCM or CSWC or ARCC or GAIN?
By revenue growth (latest reported year), Ares Capital Corporation (ARCC) is pulling ahead at 32.
9% versus -12. 9% for Gladstone Investment Corporation (GAIN). On earnings-per-share growth, the picture is similar: Ares Capital Corporation grew EPS -23. 8% year-over-year, compared to -46. 9% for Stellus Capital Investment Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SCM or CSWC or ARCC or GAIN?
Gladstone Investment Corporation (GAIN) is the more profitable company, earning 72.
7% net margin versus 26. 1% for Stellus Capital Investment Corporation — meaning it keeps 72. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GAIN leads at 72. 7% versus 48. 5% for CSWC. At the gross margin level — before operating expenses — SCM leads at 76. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SCM or CSWC or ARCC or GAIN more undervalued right now?
On forward earnings alone, Stellus Capital Investment Corporation (SCM) trades at 9.
4x forward P/E versus 40. 7x for Gladstone Investment Corporation — 31. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SCM: 37. 0% to $13. 25.
08Which pays a better dividend — SCM or CSWC or ARCC or GAIN?
In this comparison, CSWC (10.
2% yield), GAIN (10. 0% yield), ARCC (2. 0% yield) pay a dividend. SCM does not pay a meaningful dividend and should not be held primarily for income.
09Is SCM or CSWC or ARCC or GAIN better for a retirement portfolio?
For long-horizon retirement investors, Gladstone Investment Corporation (GAIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
53), 10. 0% yield, +319. 3% 10Y return). Both have compounded well over 10 years (GAIN: +319. 3%, SCM: +135. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SCM and CSWC and ARCC and GAIN?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: SCM is a small-cap high-growth stock; CSWC is a small-cap deep-value stock; ARCC is a mid-cap high-growth stock; GAIN is a small-cap deep-value stock. CSWC, ARCC, GAIN pay a dividend while SCM does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.